au.\*:("HORAI, Takeshi")
Results 1 to 22 of 22
Selection :
Micropapillary clusters in early-stage lung adenocarcinomas: A distinct cytologic sign of significantly poor prognosisHOSHI, Rira; TSUZUKU, Masafumi; HORAI, Takeshi et al.Cancer. 2004, Vol 102, Num 2, pp 81-86, issn 0008-543X, 6 p.Article
Early detection of lung cancer with laser-induced fluorescence endoscopy and spectrofluorometryKUSUNOKI, Yoko; IMAMURA, Fumio; UDA, Hiroshi et al.Chest. 2000, Vol 118, Num 6, pp 1776-1782, issn 0012-3692Article
Multi-institutional randomized phase II trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancerFUKUOKA, Masahiro; YANO, Seiji; EEK, Richard et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2237-2246, issn 0732-183X, 10 p.Article
Cytological Characteristics of Pulmonary Pleomorphic and Giant Cell CarcinomasHIROSHIMA, Kenzo; DOSAKA-AKITA, Hirotoshi; HIRANO, Takashi et al.Acta cytologica. 2011, Vol 55, Num 2, pp 173-179, issn 0001-5547, 7 p.Article
Phase II Study of Erlotinib in Japanese Patients with Advanced Non-small Cell Lung CancerTAKAHASHI, Toshiaki; YAMAMOTO, Nobuyuki; SEGAWA, Yoshihiko et al.Anticancer research. 2010, Vol 30, Num 2, pp 557-563, issn 0250-7005, 7 p.Article
A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC)HORINOUCHI, Hidehito; YAMAMOTO, Noboru; KANEDA, Hiroyasu et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 37-43, issn 0344-5704, 7 p.Article
Phase II trial of gemcitabine and irinotecan in previously treated patients with small-cell lung cancerOHYANAGI, Fumiyoshi; HORIIKE, Atsushi; OKANO, Yoshio et al.Cancer chemotherapy and pharmacology. 2008, Vol 61, Num 3, pp 503-508, issn 0344-5704, 6 p.Article
Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancerZANDER, Dani S; HORIIKE, Atsushi; NISHIO, Makoto et al.Chest. 2007, Vol 131, Num 6, issn 0012-3692, 1619-1620, 1628-1634 [9 p.]Article
Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytologySATOH, Yukitoshi; HOSHI, Rira; ISHIKAWA, Yuichi et al.The Annals of thoracic surgery. 2007, Vol 83, Num 1, pp 197-203, issn 0003-4975, 7 p.Article
Implications for Differential Diagnosis of Lung Cancer-Associated Lymphadenopathy in Lymphoepithelioid Cell Lymphoma (Lennert's Lymphoma) Arising Simultaneously with Lung CancerHOSHI, Rira; FURUTA, Noriyuki; HORAI, Takeshi et al.Acta cytologica. 2010, Vol 54, Num 2, pp 197-201, issn 0001-5547, 5 p.Article
Cytology of pulmonary adenocarcinomas showing enteric differentiationSATOH, Yukitoshi; HOSHI, Rira; TSUZUKU, Masafumi et al.Acta cytologica. 2006, Vol 50, Num 3, pp 250-256, issn 0001-5547, 7 p.Article
Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell typeNINOMIYA, Hironori; HIRAMATSU, Miyako; HORAI, Takeshi et al.Lung cancer. 2009, Vol 63, Num 2, pp 235-240, issn 0169-5002, 6 p.Article
Postoperative ischemic change in bronchial stumps after primary lung cancer resectionSATOH, Yukitoshi; OKUMURA, Sakae; NAKAGAWA, Ken et al.European journal of cardio-thoracic surgery. 2006, Vol 30, Num 1, pp 172-176, issn 1010-7940, 5 p.Article
Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancerNISHIO, Makoto; OHYANAGI, Fumiyoshi; TAGUCH, Fumiko et al.Lung cancer. 2005, Vol 48, Num 1, pp 115-119, issn 0169-5002, 5 p.Article
Association of cytologic micropapillary clusters in cytology samples with lymphatic spread in clinical stage I lung adenocarcinomasSATOH, Yukitoshi; HOSHI, Rira; HORAI, Takeshi et al.Lung cancer. 2009, Vol 64, Num 3, pp 277-281, issn 0169-5002, 5 p.Article
Phase I study of intravenous ASA404 (vadimezan) administered in combination with paclitaxel and carboplatin in Japanese patients with non-small cell lung cancerHIDA, Toyoaki; TAMIYA, Motohiro; NISHIO, Makoto et al.Cancer science. 2011, Vol 102, Num 4, pp 845-851, issn 1347-9032, 7 p.Article
Gefitinib efficacy associated with multiple expression of HER family in non-small cell lung cancerNISHIO, Makoto; TAGUCHI, Fumiko; OHYANAGI, Fumiyoshi et al.Anticancer research. 2006, Vol 26, Num 5B, pp 3761-3765, issn 0250-7005, 5 p.Article
Cytological characteristics of pulmonary large cell neuroendocrine carcinomaHIROSHIMA, Kenzo; ABE, Shosaku; TAGAWA, Yutaka et al.Lung cancer. 2005, Vol 48, Num 3, pp 331-337, issn 0169-5002, 7 p.Article
LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non―Small―Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or BothKATAKAMI, Nobuyuki; ATAGI, Shinji; NISHIO, Kazuto et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3335-3341, issn 0732-183X, 7 p.Article
Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancerNIHO, Seiji; KUNITOH, Hideo; MATSUI, Kaoru et al.Lung cancer. 2012, Vol 76, Num 3, pp 362-367, issn 0169-5002, 6 p.Article
Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrationsKUDO, Keita; OHYANAGI, Fumiyoshi; MINGYON MUN et al.Lung cancer. 2011, Vol 74, Num 3, pp 401-404, issn 0169-5002, 4 p.Article
Antipyrine test predicts pharmacodynamics in docetaxel and cisplatin combination chemotherapyNISHIO, Makoto; MATSUDA, Masanori; OHYANAGI, Fumiyoshi et al.Lung cancer. 2005, Vol 49, Num 2, pp 245-251, issn 0169-5002, 7 p.Article